Astra Biotech GmbH, as part of its expansion programme, is seeking OEM partnerships for the development of innovative diagnostics for a wide range of diseases.
Astra Biotech manufacture high quality reagents, allergens, antibodies, recombinant proteins and assays for the determination of hormones including fertility, allergies, genetic related diseases and tumour markers plus are able to supply component materials for existing products.
Astra Biotech GmbH products incorporate only certified high purity reagents and by rigorous quality control procedures in their manufacturing facilities thus enabling clear tracking of all component materials.
Astra Biotech is able to supply complete ranges of IVD compliant assays down to individual components so that partner organisations may fill gaps in their present portfolio without the expense of further research and development costs. This means that any partner would be able to increase turnover with minimal investment.
Alexandra Ghica-Cantacuzino, head of International Sales & Marketing at Astra Biotech GmbH says: “Our strategy is to become the partner of choice for diagnostics manufacturers and to be a leading supplier of components for new diagnostic procedures. Our Research and Development and our Production departments have considerable experience in regulatory compliance and are able to provide comprehensive support to suppliers when establishing new products therefore reducing the time to market without the associated costs. Astra Biotech’s goal is to assist all those involved in patient care to improve overall healthcare standards around the world."
For more information, visit www.astrabiotech.de
Astra Biotech manufacture high quality reagents, allergens, antibodies, recombinant proteins and assays for the determination of hormones including fertility, allergies, genetic related diseases and tumour markers plus are able to supply component materials for existing products.
Astra Biotech GmbH products incorporate only certified high purity reagents and by rigorous quality control procedures in their manufacturing facilities thus enabling clear tracking of all component materials.
Astra Biotech is able to supply complete ranges of IVD compliant assays down to individual components so that partner organisations may fill gaps in their present portfolio without the expense of further research and development costs. This means that any partner would be able to increase turnover with minimal investment.
Alexandra Ghica-Cantacuzino, head of International Sales & Marketing at Astra Biotech GmbH says: “Our strategy is to become the partner of choice for diagnostics manufacturers and to be a leading supplier of components for new diagnostic procedures. Our Research and Development and our Production departments have considerable experience in regulatory compliance and are able to provide comprehensive support to suppliers when establishing new products therefore reducing the time to market without the associated costs. Astra Biotech’s goal is to assist all those involved in patient care to improve overall healthcare standards around the world."
For more information, visit www.astrabiotech.de
